ADA p.Met1Arg
c.2T>G · rs1600956379 · VCV2709658
ClinGen expert panel — Severe Combined Immunodeficiency Disease VCEP
Uncertain Significance for severe combined immunodeficiency. Applied ACMG criteria (verbatim):
PVS1_Moderate PM2_Supporting PS3_Moderate
Curation rationale (ClinGen, verbatim)
The NM_000022.4(ADA):c.2T>G is a missense variant predicted to cause substitution of Methionine by Arginine at amino acid 1 (p.Met1Arg). This sequence change affects the initiator methionine of the ADA mRNA. The next possible initiation codon is at codon 52. This variant is absent from gnomAD v4.1.0, good coverage (PM2_supporting). The NM_000022.4:c.2T>G variant in ADA may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PVS1_Moderate). ADA enzyme activity assay in E. coli S3834 showed 0.01% of wild-type activity for the p.Met1Arg variant, indicating severely reduced protein function consistent with loss of function (PS3_Moderate). In summary, this variant meets the criteria to be classified as uncertain significance for SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen ClinGen SCID-VCEP: PM2_supporting, PVS1_moderate, PS3_moderate. (VCEP specifications version 2.1.0).
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | start-loss | predicted loss-of-function |
|---|---|---|
| REVEL | 0.622 | indeterminate |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 10 | GERP 1.2, phastCons 1 |
| Overall | ||
| CADD | 24.2 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ADA
- Protein
- p.Met1Arg
- Coding
- c.2T>G
- MANE Select
- NM_000022
- dbSNP
- rs1600956379
- Type
- single nucleotide variant
- Location
- chr20:44651606 (GRCh38)
- Gene constraint
- LOEUF 1.184 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 96.81 · 2 PDB
Similar variants
- ADA p.Met1Thr Pathogenic/Likely pathogenic ★★ same residue
- ADA p.Met1Val Pathogenic/Likely pathogenic ★★ same residue
- ADA c.1078+2T>A Likely pathogenic ★★★ same condition
- ADA c.219-2A>G Likely pathogenic ★★★ same condition
- ADA c.363-2A>G Likely pathogenic ★★★ same condition
- ADA c.606+1G>T Likely pathogenic ★★★ same condition
- ADA c.975+1G>A Pathogenic ★★★ same condition
- ADA c.976-1G>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada-p-met1arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown